Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial
Djillali Annane, Sean J. Pittock, Hrishikesh S. Kulkarni, Brian W. Pickering, Matt R Khoshnevis, Jason Siegel, Charles A. Powell, Pedro Castro, Tomoko Fujii, Derek Dunn, Keisha Herbin Smith, Sanjay Mitter, Shamsah Kazani, Austin Kulasekararaj
Topics & Concepts
MedicineClinical endpointInterim analysisMechanical ventilationRandomized controlled trialPopulationClinical trialSurgeryInternal medicineEnvironmental healthCOVID-19 Clinical Research StudiesComplement system in diseasesSARS-CoV-2 and COVID-19 Research